Brean Murray Carret & Co. Starts Stryker (SYK) at Hold, Sees Limited Upside

Brean Murray Carret & Co. initiates coverage on Stryker (NYSE: SYK) with a Hold.

The firm comments, "We consider SYK a premium, diversified name in orthopedics — and within Medtech for that matter, but see limited upside at current levels, given capex spending pressures on Medsurg, and hiccups overseas, which are offsetting strong hip and knee performance. Though estimates appear low risk, we see limited upside to them, and we would prefer to wait for a better entry point."

For an analyst ratings summary and ratings history on Stryker click here. For more ratings news on Stryker click here.

Shares of Stryker closed at $55.77 yesterday.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Wolfe Research Downgrades Stryker (SYK) to Peerperform
• BMO Capital Starts Energy Fuels (UUUU) at Outperform
• Seaport Global Securities Starts ADI Global Distribution (ADIG) at Buy